Study to assess analytical treatment interruption in participants who contracted HIV in VRC-01 trial April 6, 2021
HTI vaccines show promise for virus control without ART in patients with early HIV infection March 17, 2021
GSK-3640254 demonstrates safety and dose-antiviral response relationship in phase IIa trial March 15, 2021
Bi-functionalized nanoparticles described by Vall d'Hebron Institut de Recerca and collaborators March 5, 2021
RSS